Cargando…

Antiplatelet regimens after ischemic stroke or transient ischemic attack: a systematic review and updated network meta-analysis

BACKGROUND: It is still uncertain which antiplatelet regimen had the greatest net clinical benefit in patients who have suffered a transient ischemic attack or non-cardioembolic ischemic stroke, and it is necessary to choose the optimal regimen according to the clinical situation. METHODS: We utiliz...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jung, Seung Jin, Kim, Bum Joon, Kim, Chi Kyung, Shim, Sung Ryul, Jung, Jin-Man
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987873/ https://www.ncbi.nlm.nih.gov/pubmed/35402589 http://dx.doi.org/10.21037/atm-21-3748

Ejemplares similares

Antiplatelet regimens for Asian patients with ischemic stroke or transient ischemic attack: a systematic review and network meta-analysis
por: Jung, Seung Jin, et al.
Publicado: (2021)

Stopping “transient ischemic attacks” by antiplatelet withdrawal
por: Palaiodimou, Lina, et al.
Publicado: (2021)

Dual Antiplatelet Therapy after Noncardioembolic Ischemic Stroke or Transient Ischemic Attack: Pros and Cons
por: Hong, Keun-Sik
Publicado: (2014)

Transient ischemic attacks: predictability of future ischemic stroke or transient ischemic attack events
por: Gupta, Harsh V, et al.
Publicado: (2014)

2022 Update of the Korean Clinical Practice Guidelines for Stroke: Antithrombotic Therapy for Patients with Acute Ischemic Stroke or Transient Ischemic Attack
por: Park, Hong-Kyun, et al.
Publicado: (2022)

Antiplatelet Treatment After Transient Ischemic Attack and Ischemic Stroke in Patients With Cerebral Microbleeds in 2 Large Cohorts and an Updated Systematic Review
por: Lau, Kui Kai, et al.
Publicado: (2018)

Antiplatelet Therapy in the Secondary Prevention of Non-cardioembolic Ischemic Stroke and Transient Ischemic Attack: A Mini-Review
por: Vališ, Martin, et al.
Publicado: (2021)

Risk of Subsequent Events in Patients With Minor Ischemic Stroke or High-Risk Transient Ischemic Attack
por: Lee, Keon-Joo, et al.
Publicado: (2022)

Long-Term Antiplatelet Mono- and Dual Therapies After Ischemic Stroke or Transient Ischemic Attack: Network Meta-Analysis
por: Xie, Wuxiang, et al.
Publicado: (2015)

Dual vs. mono antiplatelet therapy for acute ischemic stroke or transient ischemic attack with evidence of large artery atherosclerosis
por: Lin, Chun-Jen, et al.
Publicado: (2022)

The role of CYP2C19 genotyping to guide antiplatelet therapy following ischemic stroke or transient ischemic attack
por: McDermott, John H, et al.
Publicado: (2022)

Balancing Benefits and Risks of Long-Term Antiplatelet Therapy in Noncardioembolic Transient Ischemic Attack or Stroke
por: Hilkens, Nina A., et al.
Publicado: (2021)

Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis
por: Niu, Peng-Peng, et al.
Publicado: (2016)

Dual versus mono antiplatelet therapy for acute non- cardio embolic ischemic stroke or transient ischemic attack, an efficacy and safety analysis - updated meta-analysis
por: Albay, Christessa Emille Que, et al.
Publicado: (2020)

Antiplatelet drugs for secondary prevention in patients with ischemic stroke or transient ischemic attack: a systematic review and network meta-analysis
por: Del Giovane, Cinzia, et al.
Publicado: (2021)

Cardiac Imaging After Ischemic Stroke or Transient Ischemic Attack
por: Camen, S., et al.
Publicado: (2020)

Dual antiplatelet therapy reduced stroke risk in transient ischemic attack with positive diffusion weighted imaging
por: Pei, Lu-lu, et al.
Publicado: (2020)

Benefit-risk profile of cytoreductive drugs along with antiplatelet and antithrombotic therapy after transient ischemic attack or ischemic stroke in myeloproliferative neoplasms
por: De Stefano, Valerio, et al.
Publicado: (2018)

Personalized antiplatelet therapy guided by clopidogrel pharmacogenomics in acute ischemic stroke and transient ischemic attack: A prospective, randomized controlled trial
por: Zhang, Xiaoguang, et al.
Publicado: (2023)

Camptocormia with Transient Ischemic Attack
por: Oh, Ju-Hee, et al.
Publicado: (2017)

Retraction Note: Dual versus mono antiplatelet therapy for acute non- cardio embolic ischemic stroke or transient ischemic attack, an efficacy and safety analysis - updated meta-analysis
por: Albay, Christessa Emille Que, et al.
Publicado: (2020)

Differentiation of true transient ischemic attack versus transient ischemic attack mimics
por: Noureddine, Ali, et al.
Publicado: (2014)

Antithrombotic Management of Patients with Nonvalvular Atrial Fibrillation and Ischemic Stroke or Transient Ischemic Attack: Executive Summary of the Korean Clinical Practice Guidelines for Stroke
por: Jung, Keun-Hwa, et al.
Publicado: (2015)

Statin Prescription Adhered to Guidelines for Patients Hospitalized due to Acute Ischemic Stroke or Transient Ischemic Attack
por: Hong, Keun-Sik, et al.
Publicado: (2013)

Minor Stroke and Transient Ischemic Attack: Research and Practice
por: Yakhkind, Aleksandra, et al.
Publicado: (2016)

Electrolytes and clinical outcomes in patients with acute ischemic stroke or transient ischemic attack
por: Wang, Anxin, et al.
Publicado: (2021)

Recurrent Stroke in Minor Ischemic Stroke or Transient Ischemic Attack With Metabolic Syndrome and/or Diabetes Mellitus
por: Chen, Weiqi, et al.
Publicado: (2017)

Multiple Antiplatelet Therapy in Ischemic Stroke Already on Antiplatelet Agents Based on the Linked Big Data for Stroke
por: Kim, Tae Jung, et al.
Publicado: (2023)

Impact of multiple cardiovascular medications on mortality after an incidence of ischemic stroke or transient ischemic attack
por: Ma, Tian-Tian, et al.
Publicado: (2021)

Creatine Kinase Is Associated With Recurrent Stroke and Functional Outcomes of Ischemic Stroke or Transient Ischemic Attack
por: Li, Shiyu, et al.
Publicado: (2022)

Headache in transient ischemic attacks
por: Lebedeva, Elena R., et al.
Publicado: (2018)

Serum Phosphate and 1-Year Outcome in Patients With Acute Ischemic Stroke and Transient Ischemic Attack
por: Zhang, Jun-Fang, et al.
Publicado: (2021)

Risk factors for ischemic stroke and transient ischemic attack in patients under age 50
por: Janssen, A. W. M., et al.
Publicado: (2010)

Global Brain Perfusion and the Risk of Transient Ischemic Attack and Ischemic Stroke: The Rotterdam Study
por: Fani, Lana, et al.
Publicado: (2019)

Hemoglobin Concentration and Clinical Outcomes After Acute Ischemic Stroke or Transient Ischemic Attack
por: Zhang, Runhua, et al.
Publicado: (2021)

Predictors for Returning to Paid Work after Transient Ischemic Attack and Minor Ischemic Stroke
por: Wicht, Corentin A., et al.
Publicado: (2022)

Antiplatelet Use in Ischemic Stroke
por: Kamarova, Marharyta, et al.
Publicado: (2022)

Robotic exoskeleton assessment of transient ischemic attack
por: Simmatis, Leif, et al.
Publicado: (2017)

Association of frequent premature ventricular complex >10% and stroke-like symptoms without a prior diagnosis of stroke or transient ischemic attack
por: Im, Sung Il, et al.
Publicado: (2018)

Appropriate use of antiplatelet medications following transient ischemic attacks and stroke: a 9-year study from the Middle East
por: Naveed, Hiba, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_13meph1ifo8ghr8r9k2qj1a24p